Curriculum Vitae german

Passbild: Prof. Hiemke
Prof. Dr. rer.nat. Christoph Hiemke

E-Mail: hiemke@uni-mainz.de

Positions

  • Managing director of the psiac GmbH (http://www.psiac.de)
  • Leding member of the TDM-Group of the Arbeitsgemeinschaft für Neuropsychopharmatologie und Pharmakopsychiatrie (AGNP)
  • Member of the Scientific Boards of Scientific Journals Pharmacopsychiatry and Psychopharmakotherapie

Positions Held

1968-1973 Study of Biology, University of Bonn 1974-1977 Ph.D. thesis, Pharmacological Institute, University of Bonn 1977-1987 Research Fellow at the Institute of Physiological Chemistry, University of Essen 1986 Venia legendi (Habilitation) for Physiological Chemistry, Institute of Physiological Chemistry, University of Essen 1987-2014 Head of Neurochemical Laboratory at the Department of Psychiatry and Neurology, University of Mainz    Since 2014 Emeritus

Research Interests  

  • Clinical psychopharmacology
  • Therapeutic drug monitoring
  • Drug-drug interactions

Publications  

Selected Publications

  • Hefner G, Laib AK, Sigurdsson H, Hohner M, Hiemke C. The value of drug and metabolite concentration in blood as a biomarker of psychopharmacological therapy. Int Rev Psychiatry. 2013 Oct;25(5):494-508.

  • Hefner G, Stieffenhofer V, Gabriel S, Palmer G, Müller KM, Röschke J, Hiemke C. Side effects related to potentially inappropriate medications in elderly psychiatric patients under everyday pharmacotherapy. Eur J Clin Pharmacol. 2015 Feb;71(2):165-72.

  • Spina E, Hiemke C, de Leon J. Assessing drug-drug interactions through therapeutic drug monitoring when administering oral second-generation antipsychotics. Expert Opin Drug Metab Toxicol. 2016 Apr;12(4):407-22.

  • Hiemke C. Consensus Guideline Based Therapeutic Drug Monitoring (TDM) in Psychiatry and Neurology. Curr Drug Deliv. 2016;13(3):353-61.

For PubMed listed publications „pubmed“ see (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi) and search „Hiemke C“